137 related articles for article (PubMed ID: 19393775)
1. Accumulation of oxidative stress around the stroke-like lesions of MELAS patients.
Katayama Y; Maeda K; Iizuka T; Hayashi M; Hashizume Y; Sanada M; Kawai H; Kashiwagi A
Mitochondrion; 2009 Sep; 9(5):306-13. PubMed ID: 19393775
[TBL] [Abstract][Full Text] [Related]
2. [A case of stroke-like episode of MELAS of which progressive spread would be prevented by edaravone].
Maeda K; Tatsumi M; Tahara M; Murata Y; Kawai H; Yasuda H
Rinsho Shinkeigaku; 2005 Jun; 45(6):416-21. PubMed ID: 16022465
[TBL] [Abstract][Full Text] [Related]
3. MCI-186 reduces oxidative cellular damage and increases DNA repair function in the rabbit spinal cord after transient ischemia.
Takahashi G; Sakurai M; Abe K; Itoyama Y; Tabayashi K
Ann Thorac Surg; 2004 Aug; 78(2):602-7. PubMed ID: 15276530
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction.
Uno M; Kitazato KT; Suzue A; Matsuzaki K; Harada M; Itabe H; Nagahiro S
Free Radic Biol Med; 2005 Oct; 39(8):1109-16. PubMed ID: 16198237
[TBL] [Abstract][Full Text] [Related]
5. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
6. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
Ohta M; Higashi Y; Yawata T; Kitahara M; Nobumoto A; Ishida E; Tsuda M; Fujimoto Y; Shimizu K
Brain Res; 2013 Jan; 1490():184-92. PubMed ID: 22982593
[TBL] [Abstract][Full Text] [Related]
8. Edaravone, a free radical scavenger, attenuates behavioral deficits following transient forebrain ischemia by inhibiting oxidative damage in gerbils.
Lu F; Nakamura T; Toyoshima T; Liu Y; Hirooka K; Kawai N; Okabe N; Shiraga F; Tamiya T; Miyamoto O; Keep RF; Itano T
Neurosci Lett; 2012 Jan; 506(1):28-32. PubMed ID: 22040669
[TBL] [Abstract][Full Text] [Related]
9. [MELAS syndrome (mitochondrial encephalopathy with lactic acidosis and stroke-like episodes].
Carmi E; Defossez C; Morin G; Fraitag S; Lok C; Westeel PF; Canaple S; Denoeux JP
Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1031-5. PubMed ID: 11907964
[TBL] [Abstract][Full Text] [Related]
10. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
Shimizu S; Saito M; Kinoshita Y; Kazuyama E; Tamamura M; Satoh I; Satoh K
BJU Int; 2009 Sep; 104(5):713-7. PubMed ID: 19338546
[TBL] [Abstract][Full Text] [Related]
11. Acute hearing loss in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).
Chen JC; Tsai TC; Liu CS; Lu CT
Acta Neurol Taiwan; 2007 Sep; 16(3):168-72. PubMed ID: 17966957
[TBL] [Abstract][Full Text] [Related]
12. Muscle computed tomography patterns in patients with the mitochondrial DNA mutation 3243A>G.
Kärppä M; Mahjneh I; Karttunen A; Tolonen U; Majamaa K
J Neurol; 2004 May; 251(5):556-63. PubMed ID: 15164188
[TBL] [Abstract][Full Text] [Related]
13. The novel antioxidant edaravone: from bench to bedside.
Watanabe T; Tahara M; Todo S
Cardiovasc Ther; 2008; 26(2):101-14. PubMed ID: 18485133
[TBL] [Abstract][Full Text] [Related]
14. The free-radical scavenger edaravone restores the differentiation of human neural precursor cells after radiation-induced oxidative stress.
Ishii J; Natsume A; Wakabayashi T; Takeuchi H; Hasegawa H; Kim SU; Yoshida J
Neurosci Lett; 2007 Aug; 423(3):225-30. PubMed ID: 17709197
[TBL] [Abstract][Full Text] [Related]
15. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
16. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Shinohara Y; Saito I; Kobayashi S; Uchiyama S
Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
[TBL] [Abstract][Full Text] [Related]
17. Deep white matter pathologic features in watershed regions: a novel pattern of central nervous system involvement in MELAS.
Apostolova LG; White M; Moore SA; Davis PH
Arch Neurol; 2005 Jul; 62(7):1154-6. PubMed ID: 16009776
[TBL] [Abstract][Full Text] [Related]
18. Termination of damaged protein repair defines the occurrence of symptoms in carriers of the m.3243A > G tRNA(Leu) mutation.
van Eijsden RG; Eijssen LM; Lindsey PJ; van den Burg CM; de Wit LE; Rubio-Gozalbo ME; de Die CE; Ayoubi T; Sluiter W; de Coo IF; Smeets HJ
J Med Genet; 2008 Aug; 45(8):525-34. PubMed ID: 18456717
[TBL] [Abstract][Full Text] [Related]
19. Edaravone inhibits the disease activity in rheumatoid arthritis.
Arii K; Kumon Y; Ikeda Y; Suehiro T; Hashimoto K
J Clin Pharm Ther; 2006 Apr; 31(2):197-9. PubMed ID: 16635056
[TBL] [Abstract][Full Text] [Related]
20. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
